Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BALSALAZIDE vs BARICITINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BALSALAZIDE vs BARICITINIB: Safety Overview

Metric BALSALAZIDE BARICITINIB
Total FAERS Reports 239 8,108
Deaths Reported 9 717
Death Rate 3.8% 8.8%
Hospitalizations 64 2,498
Average Patient Age 50.6 yrs 58.2 yrs
% Female Patients 59.8% 67.9%
FDA Approval Date Apr 3, 2025 Aug 8, 2025
Manufacturer AvPAK Eli Lilly and Company
Route ORAL ORAL
Marketing Status Prescription Prescription